Alexium International Group Limited

Alexium International Group Limited manufactures and sells phase-change material (PCM) and other specialty textile solutions in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM chemical finish for fabrics; Biocool, a natural and biobased PCM cooling for textile and foam bedding applications; and Eclipsys, a perpetual cooling technology that enhance the cooling experience for textile and foam bedding systems. The company also provides flame retardant solutions, such as Alexiflam, a flame-retardant treatment for cotton, linen, and other cellulosic textiles, as well as mattress applications. It serves bedding, military, and workwear markets. The company was incorporated in 1994 and is based in Greer, South Carolina.

Alexium International Group Limited trades as AXIIF on OTC. The company is classified in Basic Materials / Chemicals - Specialty and reports in USD.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $3.92M of revenue and -$3.93M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Alexium International Group Limited can be compared against peers such as ArcPacific Resources Corp., Nordique Resources Inc., Chesser Resources Limited, China Nonferrous Gold Limited, Olympio Metals Limited, Citigold Corporation Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $18.63M, beta of 0.61, and return on equity of +977.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

AXIIF currently shows total debt of $2.55M and beta of 0.61. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.alexiuminternational.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.